Our proprietary technology is proven to trigger neo-collagenesis, which increases collagen and stimulates elastin and hyaluronic acid production
Recently, the FDA has approved select GLP-1 therapies specifically for weight loss, including: Wegovy Saxenda Zepbound, a GIP/GLP-1 dual-acting therapy Of course, successful weight loss treatment is incredible news for the 42 percent of Americans who have obesity
At full therapeutic doses, roughly 40% of patients experience GI side effects severe enough to consider stopping
If you are weighing its protocol profile against the current dual-agonist benchmark, read our tirzepatide vs retatrutide article
However, she was only able to fast for 15 to 17 hours, and the test was ended earlier, with no evidence of hypoglycemia during the test
Shokri-Kojori E, Tomasi D, Alipanahi B, Wiers CE, Wang GJ, Volkow ND